Home » TB ALLIANCE AND BG MEDICINE INITIATE BIOMARKER DISCOVERY PROGRAM
TB ALLIANCE AND BG MEDICINE INITIATE BIOMARKER DISCOVERY PROGRAM
The Global Alliance for TB Drug Development (TB Alliance) and BG Medicine Inc. announced today a collaboration to identify biomarkers for drug efficacy in the treatment of tuberculosis (TB), a step toward faster and more efficient drug development. "The clock is ticking, we need to find a faster cure for TB, and new biomarkers could expedite our search," said Dr. Maria C. Freire, President and CEO of the TB Alliance.
Athens News Agency (http://www.ana.gr/anaweb/user/showprel?service=3&maindoc=3972043)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May